0 Ratings
ID

43210

Description

ODM derived from http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Link

http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Keywords

Versions (4)
  1. 2/16/12 2/16/12 -
  2. 4/13/14 4/13/14 - Julian Varghese
  3. 8/10/14 8/10/14 - Martin Dugas
  4. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility NCT00334295 Metastatic Endometrial Carcinoma

    German English

    Eligibility

    1 forms  
    1. StudyEvent: Eligibility
      1. Eligibility
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI-1
    C1512693
    18 Years and older
    Description

    Age

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0001779
    Female Gender
    Description

    Female Gender

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0086287
    Histologically confirmed, recurrent or metastatic endometrial carcinoma
    Description

    Metastatic endometrial carcinoma

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0813148
    Postmenopausal
    Description

    Postmenopausal

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0232970
    Hormonreceptor positive tumor
    Description

    Hormonreceptor positive tumor

    Data type

    boolean

    Alias
    UMLS CUI-1
    C1563119
    Exclusion criteria
    Description

    Exclusion criteria

    Alias
    UMLS CUI-1
    C0680251
    Pre-treatment with Fulvestrant
    Description

    Pre-treatment with Fulvestrant

    Data type

    boolean

    Alias
    UMLS CUI-1
    C1550147
    Previous endocrine therapy of the endometrial carcinoma
    Description

    Previous endocrine therapy

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0262926
    UMLS CUI-2
    C0279025
    Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
    Description

    Previous malignancy

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0262926
    UMLS CUI-2
    C0006826
    Back to the top of the page

    Similar models

    Eligibility

    1 forms
    1. StudyEvent: Eligibility
      1. Eligibility
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Inclusion Criteria
    C1512693 (UMLS CUI-1)
    Age
    Item
    18 Years and older
    boolean
    C0001779 (UMLS CUI-1)
    Female
    Item
    Female Gender
    boolean
    C0086287 (UMLS CUI-1)
    Metastatic endometrial carcinoma
    Item
    Histologically confirmed, recurrent or metastatic endometrial carcinoma
    boolean
    C0813148 (UMLS CUI-1)
    Postmenopausal
    Item
    Postmenopausal
    boolean
    C0232970 (UMLS CUI-1)
    Hormonreceptor positive tumor
    Item
    Hormonreceptor positive tumor
    boolean
    C1563119 (UMLS CUI-1)
    Item Group
    Exclusion criteria
    C0680251 (UMLS CUI-1)
    Pre-treatment with Fulvestrant
    Item
    Pre-treatment with Fulvestrant
    boolean
    C1550147 (UMLS CUI-1)
    Previous endocrine therapy
    Item
    Previous endocrine therapy of the endometrial carcinoma
    boolean
    C0262926 (UMLS CUI-1)
    C0279025 (UMLS CUI-2)
    Previous malignancy
    Item
    Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
    boolean
    C0262926 (UMLS CUI-1)
    C0006826 (UMLS CUI-2)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial